Post-treatment control of HIV infection
Journal Article
·
· Proceedings of the National Academy of Sciences of the United States of America
- The Pennsylvania State Univ., University Park, PA (United States); Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Antiretroviral therapy (ART) for HIV is not a cure. However, recent studies suggest that ART, initiated early during primary infection, may induce post-treatment control (PTC) of HIV infection with HIV RNA maintained at <50 copies per mL. We investigate the hypothesis that ART initiated early during primary infection permits PTC by limiting the size of the latent reservoir, which, if small enough at treatment termination, may allow the adaptive immune response to prevent viral rebound (VR) and control infection. We use a mathematical model of within host HIV dynamics to capture interactions among target cells, productively infected cells, latently infected cells, virus, and cytotoxic T lymphocytes (CTLs). Analysis of our model reveals a range in CTL response strengths where a patient may show either VR or PTC, depending on the size of the latent reservoir at treatment termination. Below this range, patients will always rebound, whereas above this range, patients are predicted to behave like elite controllers. As a result, using data on latent reservoir sizes in patients treated during primary infection, we also predict population-level VR times for non-controllers consistent with observations.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE
- Grant/Contract Number:
- AC52-06NA25396
- OSTI ID:
- 1233166
- Report Number(s):
- LA--UR-14-27986
- Journal Information:
- Proceedings of the National Academy of Sciences of the United States of America, Journal Name: Proceedings of the National Academy of Sciences of the United States of America Journal Issue: 17 Vol. 112; ISSN 0027-8424
- Publisher:
- National Academy of Sciences, Washington, DC (United States)Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Modeling the effects of vorinostat in vivo reveals both transient and delayed HIV transcriptional activation and minimal killing of latently infected cells
Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
Deep latency: A new insight into a functional HIV cure
Journal Article
·
Thu Oct 22 20:00:00 EDT 2015
· PLoS Pathogens
·
OSTI ID:1235937
Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
Journal Article
·
Tue Jul 23 20:00:00 EDT 2019
· PLoS Computational Biology (Online)
·
OSTI ID:1627260
Deep latency: A new insight into a functional HIV cure
Journal Article
·
Sun Jun 30 20:00:00 EDT 2019
· EBioMedicine
·
OSTI ID:1570103